These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20210117)

  • 21. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine to begin human trials.
    AIDS Patient Care STDS; 2003 Aug; 17(8):437. PubMed ID: 14619927
    [No Abstract]   [Full Text] [Related]  

  • 23. AIDS vaccine test to be expanded based on upbeat results.
    AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of volunteers for vaccine.
    AIDS Patient Care STDS; 1999 Sep; 13(9):572. PubMed ID: 10813047
    [No Abstract]   [Full Text] [Related]  

  • 25. Volunteers sought for NIH AIDS vaccine study.
    AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16329177
    [No Abstract]   [Full Text] [Related]  

  • 26. Adaptive clinical trial designs proposed to accelerate development of HIV vaccines.
    Expert Rev Vaccines; 2011 Jun; 10(6):717. PubMed ID: 21692694
    [No Abstract]   [Full Text] [Related]  

  • 27. An HIV vaccine: as we build it, will they come?
    McCluskey MM; Alexander SB; Larkin BD; Murguia M; Wakefield S
    Health Aff (Millwood); 2005; 24(3):643-51. PubMed ID: 15886155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine study is enrolling.
    AIDS Patient Care STDS; 2005 Apr; 19(4):276-7. PubMed ID: 15920787
    [No Abstract]   [Full Text] [Related]  

  • 29. First AIDS vaccine trial in Germany.
    AIDS Patient Care STDS; 2004 Apr; 18(4):251. PubMed ID: 15156601
    [No Abstract]   [Full Text] [Related]  

  • 30. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
    Hanke T; McMichael AJ
    Nat Med; 2000 Sep; 6(9):951-5. PubMed ID: 10973301
    [No Abstract]   [Full Text] [Related]  

  • 31. Before you volunteer..
    von Ornsteiner JB
    Body Posit; 2004; 17(4):24-5. PubMed ID: 15929212
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccine research going back to square one.
    AIDS Read; 2008 Apr; 18(4):166, 208. PubMed ID: 18472426
    [No Abstract]   [Full Text] [Related]  

  • 33. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eureka! Success of combo HIV vaccine raises hopes, should revitalize research. An HIV vaccine shows surprising efficacy in human trials.
    AIDS Alert; 2009 Nov; 24(11):121-3. PubMed ID: 19960605
    [No Abstract]   [Full Text] [Related]  

  • 35. Outstanding questions on HIV vaccine trial.
    Jefferys R; Harrington M
    Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
    [No Abstract]   [Full Text] [Related]  

  • 36. One-two combination.
    von Bubnoff A
    IAVI Rep; 2007; 11(3):11-4. PubMed ID: 20210046
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule: summary.
    Gorse GJ
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S141-3. PubMed ID: 7865289
    [No Abstract]   [Full Text] [Related]  

  • 38. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
    Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Support for the RV144 HIV vaccine trial.
    Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
    [No Abstract]   [Full Text] [Related]  

  • 40. Broadening inclusion of vulnerable populations in HIV vaccine trials.
    Lau CY; Cardinali M; Sato PA; Fix A; Flores J
    Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.